Pulmonary Eosinophilia - 20 Studies Found
| Active, not recruiting |
: Omalizumab to Mepolizumab Switch Study in Severe Eosinophilic Asthma Patients : Asthma : 2016-01-11 :
|
| Recruiting |
: A Study of Reslizumab in Patients 12 Years of Age and Older With Severe Eosinophilic Asthma : Eosinophils, Asthma : 2017-02-07 : Drug: reslizumab 110-mg |
| Completed |
: Efficacy, Safety, and Tolerability of SAR231893 (REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma : Asthma : 2011-03-09 :
|
| Enrolling by invitation |
: Anti-Interleukin-5 (IL5) Monoclonal Antibody (MAb) in Prednisone-dependent Eosinophilic Asthma :
: 2015-09-22 :
|
| Recruiting |
: Study of Mepolizumab Autoinjector in Asthmatics : Asthma : 2017-03-29 : Drug: Mepolizumab It is a clear to opalescent, colorless to pale yellow sterile solution for SC injectio |
| Active, not recruiting |
: Study of Mepolizumab Safety Syringe in Asthmatics : Asthma : 2017-01-12 : Drug: Mepolizumab It is a clear to opalescent, colorless to pale yellow sterile solution for SC injectio |
| Active, not recruiting |
: Pharmacokinetics and Pharmacodynamics of Mepolizumab Administered Subcutaneously in Children : Asthma : 2015-02-26 : Drug: Mepolizumab Mepolizumab is supplied as 100 mg lyophilised cake in sterile vials for subcutaneous a |
| Recruiting |
: An Imaging Study Using PET/CT to Characterize the Effect of Intravenous Reslizumab on Airway Inflammation : Asthma : 2016-10-14 :
|
| Completed |
: Small Particle Steroids in Refractory Asthma : Asthma : 2010-06-24 :
|
| Active, not recruiting |
: A Phase 3a, Repeat Dose, Open-label, Long-term Safety Study of Mepolizumab in Asthmatic Subjects : Asthma : 2014-05-08 :
|